1.Risks, mechanisms, and prevention strategies for cerebrovascular diseases in lunar astronauts under deep.
Lei TANG ; Qiaoling TANG ; Ye LI ; Li WANG ; Feng ZHANG ; Xiangbin ZHANG ; Ran LIU ; Le ZHANG
Journal of Central South University(Medical Sciences) 2025;50(8):1337-1345
As human deep space exploration enters a practical phase, ensuring astronaut health and safety has become a critical determinant of mission success. The cerebrovascular system, essential for maintaining brain function, is highly sensitive to environmental changes. Cerebrovascular diseases represent one of the characteristic adverse effects of deep space conditions such as microgravity and high-energy radiation, and have emerged as a frontier challenge in space medicine. Based on experiences from manned space missions, major research challenges persist, particularly the lack of experimental data specific to the lunar environment and the unclear threshold for low-dose radiation-induced injury. Elucidating the mechanisms and multifactorial interactions by which deep space environments impact cerebrovascular structure and function, and summarizing the key risk factors, pathological processes, and recent advances in monitoring and early-warning technologies for cerebrovascular diseases in lunar astronauts, and of crucial importance. A comprehensive understanding of the interplay between deep space environmental stressors and cerebrovascular injury, as well as the development of personalized prevention and intervention strategies, will provide both theoretical and practical foundations for safeguarding cerebrovascular health in future Chinese deep space missions, while promoting progress in related biomedical research, technological innovation, and international collaboration.
Humans
;
Astronauts
;
Cerebrovascular Disorders/etiology*
;
Space Flight
;
Weightlessness/adverse effects*
;
Risk Factors
;
Moon
3.Chinese expert consensus on blood support mode and blood transfusion strategies for emergency treatment of severe trauma patients (version 2024)
Yao LU ; Yang LI ; Leiying ZHANG ; Hao TANG ; Huidan JING ; Yaoli WANG ; Xiangzhi JIA ; Li BA ; Maohong BIAN ; Dan CAI ; Hui CAI ; Xiaohong CAI ; Zhanshan ZHA ; Bingyu CHEN ; Daqing CHEN ; Feng CHEN ; Guoan CHEN ; Haiming CHEN ; Jing CHEN ; Min CHEN ; Qing CHEN ; Shu CHEN ; Xi CHEN ; Jinfeng CHENG ; Xiaoling CHU ; Hongwang CUI ; Xin CUI ; Zhen DA ; Ying DAI ; Surong DENG ; Weiqun DONG ; Weimin FAN ; Ke FENG ; Danhui FU ; Yongshui FU ; Qi FU ; Xuemei FU ; Jia GAN ; Xinyu GAN ; Wei GAO ; Huaizheng GONG ; Rong GUI ; Geng GUO ; Ning HAN ; Yiwen HAO ; Wubing HE ; Qiang HONG ; Ruiqin HOU ; Wei HOU ; Jie HU ; Peiyang HU ; Xi HU ; Xiaoyu HU ; Guangbin HUANG ; Jie HUANG ; Xiangyan HUANG ; Yuanshuai HUANG ; Shouyong HUN ; Xuebing JIANG ; Ping JIN ; Dong LAI ; Aiping LE ; Hongmei LI ; Bijuan LI ; Cuiying LI ; Daihong LI ; Haihong LI ; He LI ; Hui LI ; Jianping LI ; Ning LI ; Xiying LI ; Xiangmin LI ; Xiaofei LI ; Xiaojuan LI ; Zhiqiang LI ; Zhongjun LI ; Zunyan LI ; Huaqin LIANG ; Xiaohua LIANG ; Dongfa LIAO ; Qun LIAO ; Yan LIAO ; Jiajin LIN ; Chunxia LIU ; Fenghua LIU ; Peixian LIU ; Tiemei LIU ; Xiaoxin LIU ; Zhiwei LIU ; Zhongdi LIU ; Hua LU ; Jianfeng LUAN ; Jianjun LUO ; Qun LUO ; Dingfeng LYU ; Qi LYU ; Xianping LYU ; Aijun MA ; Liqiang MA ; Shuxuan MA ; Xainjun MA ; Xiaogang MA ; Xiaoli MA ; Guoqing MAO ; Shijie MU ; Shaolin NIE ; Shujuan OUYANG ; Xilin OUYANG ; Chunqiu PAN ; Jian PAN ; Xiaohua PAN ; Lei PENG ; Tao PENG ; Baohua QIAN ; Shu QIAO ; Li QIN ; Ying REN ; Zhaoqi REN ; Ruiming RONG ; Changshan SU ; Mingwei SUN ; Wenwu SUN ; Zhenwei SUN ; Haiping TANG ; Xiaofeng TANG ; Changjiu TANG ; Cuihua TAO ; Zhibin TIAN ; Juan WANG ; Baoyan WANG ; Chunyan WANG ; Gefei WANG ; Haiyan WANG ; Hongjie WANG ; Peng WANG ; Pengli WANG ; Qiushi WANG ; Xiaoning WANG ; Xinhua WANG ; Xuefeng WANG ; Yong WANG ; Yongjun WANG ; Yuanjie WANG ; Zhihua WANG ; Shaojun WEI ; Yaming WEI ; Jianbo WEN ; Jun WEN ; Jiang WU ; Jufeng WU ; Aijun XIA ; Fei XIA ; Rong XIA ; Jue XIE ; Yanchao XING ; Yan XIONG ; Feng XU ; Yongzhu XU ; Yongan XU ; Yonghe YAN ; Beizhan YAN ; Jiang YANG ; Jiangcun YANG ; Jun YANG ; Xinwen YANG ; Yongyi YANG ; Chunyan YAO ; Mingliang YE ; Changlin YIN ; Ming YIN ; Wen YIN ; Lianling YU ; Shuhong YU ; Zebo YU ; Yigang YU ; Anyong YU ; Hong YUAN ; Yi YUAN ; Chan ZHANG ; Jinjun ZHANG ; Jun ZHANG ; Kai ZHANG ; Leibing ZHANG ; Quan ZHANG ; Rongjiang ZHANG ; Sanming ZHANG ; Shengji ZHANG ; Shuo ZHANG ; Wei ZHANG ; Weidong ZHANG ; Xi ZHANG ; Xingwen ZHANG ; Guixi ZHANG ; Xiaojun ZHANG ; Guoqing ZHAO ; Jianpeng ZHAO ; Shuming ZHAO ; Beibei ZHENG ; Shangen ZHENG ; Huayou ZHOU ; Jicheng ZHOU ; Lihong ZHOU ; Mou ZHOU ; Xiaoyu ZHOU ; Xuelian ZHOU ; Yuan ZHOU ; Zheng ZHOU ; Zuhuang ZHOU ; Haiyan ZHU ; Peiyuan ZHU ; Changju ZHU ; Lili ZHU ; Zhengguo WANG ; Jianxin JIANG ; Deqing WANG ; Jiongcai LAN ; Quanli WANG ; Yang YU ; Lianyang ZHANG ; Aiqing WEN
Chinese Journal of Trauma 2024;40(10):865-881
Patients with severe trauma require an extremely timely treatment and transfusion plays an irreplaceable role in the emergency treatment of such patients. An increasing number of evidence-based medicinal evidences and clinical practices suggest that patients with severe traumatic bleeding benefit from early transfusion of low-titer group O whole blood or hemostatic resuscitation with red blood cells, plasma and platelet of a balanced ratio. However, the current domestic mode of blood supply cannot fully meet the requirements of timely and effective blood transfusion for emergency treatment of patients with severe trauma in clinical practice. In order to solve the key problems in blood supply and blood transfusion strategies for emergency treatment of severe trauma, Branch of Clinical Transfusion Medicine of Chinese Medical Association, Group for Trauma Emergency Care and Multiple Injuries of Trauma Branch of Chinese Medical Association, Young Scholar Group of Disaster Medicine Branch of Chinese Medical Association organized domestic experts of blood transfusion medicine and trauma treatment to jointly formulate Chinese expert consensus on blood support mode and blood transfusion strategies for emergency treatment of severe trauma patients ( version 2024). Based on the evidence-based medical evidence and Delphi method of expert consultation and voting, 10 recommendations were put forward from two aspects of blood support mode and transfusion strategies, aiming to provide a reference for transfusion resuscitation in the emergency treatment of severe trauma and further improve the success rate of treatment of patients with severe trauma.
4.Distribution of resistance genes and virulence genes in multidrug-resistant Salmonella typhimurium strains
Yufeng ZHANG ; He SONG ; Le YAN ; Pengfei XU ; Ruiqing LIU ; Tiantian TANG ; Xiaoyan WANG ; Huiling DENG ; Kairui LEI
Chinese Pediatric Emergency Medicine 2024;31(11):831-835
Objective:To study the distribution of drug resistance genes and virulence genes in multidrug-resistant Salmonella typhimurium strains.Methods:A total of 96 strains of Salmonella typhimurium were collected,and drug sensitivity tests were performed to evaluate the drug resistance and multidrug-resistance of Salmonella typhimurium.Multidrug-resistant Salmonella typhimurium strains were selected to conducted whole genome sequencing,and the distribution of drug resistance genes and virulence genes in the strain were analyzed.Results:Salmonella typhimurium strains had the highest resistance rates to ampicillin and ampicillin/sulbactam,with 89.58% and 76.04%,respectively.Followed by trimethoprim/sulfamethoxazole,ceftriaxone,and aztreonam,with 47.92%,38.54% and 33.33%,respectively,and low resistance rates to ciprofloxacin and levofloxacin,with 8.33% and 4.17%,respectively.Ninety-six strains were all sensitive to carbapenem antibiotics and piperacillin/tazobactam.Fifty-seven strains(59.38%)of Salmonella typhimurium showed multidrug-resistance.Resistance genes were detected in all 57 multidrug-resistant Salmonella typhimurium strains,with higher carrier rates of 98.25%,77.19%,and 59.65% for aac(6')-Iaa,aadA22,and blaTEM-1B,respectively.The multidrug-resistant Salmonella typhimurium strains had the highest carrier rates for invA,sipA,sseL,and sopB.Conclusion:Multidrug-resistant Salmonella typhimurium strains have a high incidence and a high carrier rate for multiple drug resistance genes and virulence genes.The monitoring and prevention of Salmonella typhimurium should be strengthened in the clinic in order to reduce the spreading epidemic of multidrug-resistant strains.
5.Phosphorylated PKM2 regulates endothelium-dependent vasodilation in diabetes.
Bin LU ; Lei TANG ; Le LI ; Xiaoyu ZHOU ; Yiping LENG ; Chengxuan QUAN
Journal of Central South University(Medical Sciences) 2023;48(5):663-670
OBJECTIVES:
Endothelium-dependent vasodilation dysfunction is the pathological basis of diabetic macroangiopathy. The utilization and adaptation of endothelial cells to high glucose determine the functional status of endothelial cells. Glycolysis pathway is the major energy source for endothelial cells. Abnormal glycolysis plays an important role in endothelium-dependent vasodilation dysfunction induced by high glucose. Pyruvate kinase isozyme type M2 (PKM2) is one of key enzymes in glycolysis pathway, phosphorylation of PKM2 can reduce the activity of pyruvate kinase and affect the glycolysis process of glucose. TEPP-46 can stabilize PKM2 in its tetramer form, reducing its dimer formation and phosphorylation. Using TEPP-46 as a tool drug to inhibit PKM2 phosphorylation, this study aims to explore the impact and potential mechanism of phosphorylated PKM2 (p-PKM2) on endothelial dependent vasodilation function in high glucose, and to provide a theoretical basis for finding new intervention targets for diabetic macroangiopathy.
METHODS:
The mice were divided into 3 groups: a wild-type (WT) group (a control group, C57BL/6 mice) and a db/db group (a diabetic group, db/db mice), which were treated with the sodium carboxymethyl cellulose solution (solvent) by gavage once a day, and a TEPP-46 group (a treatment group, db/db mice+TEPP-46), which was gavaged with TEPP-46 (30 mg/kg) and sodium carboxymethyl cellulose solution once a day. After 12 weeks of treatment, the levels of p-PKM2 and PKM2 protein in thoracic aortas, plasma nitric oxide (NO) level and endothelium-dependent vasodilation function of thoracic aortas were detected. High glucose (30 mmol/L) with or without TEPP-46 (10 μmol/L), mannitol incubating human umbilical vein endothelial cells (HUVECs) for 72 hours, respectively. The level of NO in supernatant, the content of NO in cells, and the levels of p-PKM2 and PKM2 protein were detected. Finally, the effect of TEPP-46 on endothelial nitric oxide synthase (eNOS) phosphorylation was detected at the cellular and animal levels.
RESULTS:
Compared with the control group, the levels of p-PKM2 in thoracic aortas of the diabetic group increased (P<0.05). The responsiveness of thoracic aortas in the diabetic group to acetylcholine (ACh) was 47% lower than that in the control group (P<0.05), and that in TEPP-46 treatment group was 28% higher than that in the diabetic group (P<0.05), while there was no statistically significant difference in the responsiveness of thoracic aortas to sodium nitroprusside (SNP). Compared with the control group, the plasma NO level of mice decreased in the diabetic group, while compared with the diabetic group, the phosphorylation of PKM2 in thoracic aortas decreased and the plasma NO level increased in the TEPP-46 group (both P<0.05). High glucose instead of mannitol induced the increase of PKM2 phosphorylation in HUVECs and reduced the level of NO in supernatant (both P<0.05). HUVECs incubated with TEPP-46 and high glucose reversed the reduction of NO production and secretion induced by high glucose while inhibiting PKM2 phosphorylation (both P<0.05). At the cellular and animal levels, TEPP-46 reversed the decrease of eNOS (ser1177) phosphorylation induced by high glucose (both P<0.05).
CONCLUSIONS
p-PKM2 may be involved in the process of endothelium-dependent vasodilation dysfunction in Type 2 diabetes by inhibiting p-eNOS (ser1177)/NO pathway.
Animals
;
Humans
;
Mice
;
Carboxymethylcellulose Sodium/pharmacology*
;
Diabetes Mellitus, Type 2/metabolism*
;
Endothelium, Vascular/metabolism*
;
Glucose/metabolism*
;
Human Umbilical Vein Endothelial Cells
;
Mice, Inbred C57BL
;
Nitric Oxide/metabolism*
;
Nitric Oxide Synthase Type III/metabolism*
;
Phosphorylation
;
Pyruvate Kinase/metabolism*
;
Vasodilation
6.Comparative Performance of Four Creatinine-based GFR Estimating Equations
Pei-jia LIU ; Hong-quan PENG ; Xing-hua GUO ; Lei-le TANG ; Shao-min LI ; Jia FANG ; Xun LIU
Journal of Sun Yat-sen University(Medical Sciences) 2022;43(4):621-630
ObjectiveTo assess the predictive performance of four creatinine-based equations for estimated glomerular filtration rate (eGFR): 2012 chronic kidney disease epidemiology collaboration (CKD-EPIcr) equation , 2021CKD-EPIcr equation, Xiangya equation and European kidney function consortium (EKFC) equation. MethodsA total of 198 patients with chronic kidney disease from the Third Affiliated Hospital of Sun Yat-sen University and the Kiang Wu Hospital in Macau were enrolled. We compared the GFR measured (mGFR) by iohexol plasma clearance and the eGFR calculated by four equations. The agreement between mGFR and eGFR was analyzed by Bland-Altman plots, concordance correlation coefficient (CCC), coverage probability (CP) and total deviation index (TDI). The performance of eGFR equations, including their bias, precision, root square mean error (RSME), and percentage of estimates within 30% deviation of measured GFR (P30), were evaluated. Bootstrap method (2 000 samples) was used to calculate bias, interquartile range (IQR), RSME, and 95% confidence intervals (CI) for P30. After selecting the optimal eGFR equation as the reference, we statisticlly tested other equations by ① Wilcoxon signed-rank test for bias; ② McNemar-Bowker test for P30; ③ comparing RMSE and IQR with independent samples t test after 2 000 bootstrap samples were obtained. ResultsThe median mGFR and four eGFR equations (EKFC, 2012CKD-EPIcr, 2021CKD-EPIcr and Xiangya equation) in the overall population were 56.2 mL·min-1·(1.73m2)-1, 67.1 mL·min-1·(1.73m2)-1, 73.0 mL·min-1·(1.73m2)-1, 66.9 mL·min-1·(1.73m2)-1 and 63.8 mL·min-1·(1.73m2)-1, respectively. The Bland-Altman plots showed that EKFC equation had the lowest mean difference and the narrowest 95% limit of agreement. The EKFC equation had the optimal performance on CCC, TDI and CP with values of 0.90, 24.41 and 0.50, respectively. Overall, the bias, accuracy, P30 and RSME from the EKFC equation was -0.99, 14.64, 0.80, and 14.68, respectively, with 95% CI ranging from -2.53 to 0.94, 11.82 to 17.35, 0.73 to 0.85, and 12.69 to 17.35, respectively, which were superior to those values from other three eGFR equations. The differences were statistically significant (all P < 0.05). The results in the mGFR subgroups were basically consistent with the overall trend. ConclusionsOf the four eGFR equations validated in this study, the EKFC equation comprehensively surpasses 2012CKD-EPIcr equation, 2021CKD-EPIcr equation, and Xiangya equation. With P30>75%, the EKFC equation can meet clinical diagnostic needs. Therefore, the EKFC equation is recommended for estimating GFR in a Chinese population, but more participants need be included to further support this conclusion.
7.Predictive Effect of High Density Lipoprotein to C-reactive Protein Ratio on Progression of Chronic Kidney Disease in Non-Dialysis Patient
Lei-le TANG ; Xing-hua GUO ; Shao-min LI ; Pei-jia LIU ; Jia FANG ; Xun LIU
Journal of Sun Yat-sen University(Medical Sciences) 2022;43(2):305-315
ObjectiveTo investigate the predictive effect of high density lipoprotein (HDL) to C-reactive protein (CRP) ratio (HDL/CRP) on the progression of chronic kidney disease (CKD) in non-dialysis patients. MethodsNon-dialysis chronic kidney disease patients with at least two sets of follow-up data from the Third Affiliated Hospital of Sun Yat-sen University (Tian-he and Ling-nan districts)from 2015 to 2019 were enrolled. The baseline demographic characteristics and biochemical examination results were collected from the electronic medical record system. The patients were grouped according to the quantile of Ln(HDL/CRP). The demographic and biochemical data were compared among groups by one-way ANOVA for normal distribution continuous variables, Kruskal-Wallis rank-sum test for non-normal distribution continuous variables, and Chi-square analysis for categorical variables. The relationship between HDL/CRP and baseline eGFR was investigated by correlation analysis, univariate and multivariate linear regression analysis. The Cox survival analysis were used to investigate the predictive effect of Ln(HDL/CRP) on renal deterioration events. ResultsTotally 9 142 patients with CKD were enrolled, and 439 patients were included in the end. There were 100 patients (22.8%) with chronic glomerulonephritis, 145 patients (33%) with diabetic nephropathy, 40 patients (9.1%) with hypertensive nephropathy, and 154 patients (35.1%) with other causes. According to Ln(HDL/CRP) quartile, group Quartile4 had a lower incidence of renal deterioration than the other three groups (11% vs. 21.1% to 21.8%) and had the highest baseline eGFR level. From Quartile1 to quartile 4 groups, age, Hba1c and APOA1 levels decreased gradually. The prevalence of chronic heart failure, BMI, hemoglobin, albumin, TC, LDL, TG, APOB100 levels were different among groups. Through correlation analysis, Ln (HDL/CRP) were positively correlated with baseline eGFR(r=0.162, P=0.001). After adjusting for a variety of factors by Cox regression analysis, Ln (HDL/CRP) could be included in the final equation when defined deterioration of renal function as end point [HR=0.79, 95%CI (0.69, 0.91), P=0.001]. ConclusionHDL/CRP can reflect the severity of chronic kidney disease, and the ratio of HDL and CRP can predict the progression of chronic kidney disease in non-dialysis patient.
8.Association between Metabolic Syndrome and Rapid Decline of Estimated Glomerular Filtration Rate in Middle-Aged and Elderly Populations
Pei-jia LIU ; Jia FANG ; Shao-min LI ; Lei-le TANG ; Xun LIU
Journal of Sun Yat-sen University(Medical Sciences) 2022;43(3):488-495
ObjectiveTo investigate the association of metabolic syndrome (MetS) and its components with rapid estimated glomerular filtration rate (eGFR) decline. MethodsThe China health and retirement longitudinal study (CHARLS) is a nationally representative cohort study focusing on physical and psychological health as well as social activities of middle-aged and elderly households. Cohort data could be obtained free of charge after application at the CHARLS website. We screened baseline data in 2011 and follow-up data in 2015 of CHARLS, selected those populations aged 45 and older, eGFR≥60 mL·min-1·(1.73m2)-1, without previous malignant tumors, heart disease, stroke and kidney disease, excluding those with missing values and outliers. Rapid eGFR decline was defined as an average annual decrease in eGFR of more than 3 mL·min-1·(1.73m2)-1. The 4400 participants enrolled were categorized into rapid eGFR decline group (770) and non-rapid eGFR decline group (3 630). Logistic regression was performed to test the association of MetS and its components with rapid decline of eGFR. ResultsCompared with subjects without MetS, in subjects with MetS, we found no association between MetS and rapid eGFR decline after controlling for confounding factors (P>0.05), with an OR (95%CI) of 0.988 (0.811~1.204). After adjustment for confounding factors, the MetS components associated with rapid eGFR decline were central obesity (OR = 0.968, 95% CI: 0.778~1.204, P = 0.767), elevated blood glucose (OR = 0.840, 95% CI: 0.715~0.986, P = 0.032), hypertension (OR = 1.087, 95% CI: 0.919~1.285, P = 0.328), decreased high-density lipoprotein cholesterol (OR = 1.085, 95% CI: 0.895~1.316, P = 0.404) and elevated triglyceride (OR = 1.110, 95% CI: 0.918~1.343, P = 0.281). ConclusionsMetS was not an independent risk factor of rapid eGFR decline in the middle-aged and elderly populations, and elevated blood glucose was associated with the reduced risk of rapid eGFR decline. The false renal benefit caused by elevated blood sugar might be related to the renal hyperperfusion and hyperfiltration in the early stage of the disease. We need further follow-up to observe the dynamic effects of the MetS and its components on renal function.
9.Comparative study on the effect of Danggui-Chuanxiong herb pair on vasoactive substances and adhesion molecules in the serum of acute blood stasis in rats using PLS-DA and multi-attribute comprehensive index methods
Wei-xia LI ; Xiao-yan WANG ; Jin-fa TANG ; Shu-qi ZHANG ; Yan WANG ; Hui ZHANG ; Xian-lei LIU ; Xiang-le MENG ; Xue-lin LI ; Yu-ping TANG
Acta Pharmaceutica Sinica 2019;54(11):1909-1917
We evaluated the effects of Danggui-Chuanxiong (GX) herb pair with different proportions (1∶0, 3∶2, 1∶1, 2∶3, 0∶1) and preparation methods (water extract W, alcohol extract A, and water-alcohol extracts WA) on vasoactive substances and endothelial cell adhesion molecules in the serum of acute blood stasis in rats. An acute blood stasis model was co-replicated by ice water bath and subcutaneous injection of epinephrine hydrochloride in rats. The expressions of vasoactive substances (arachidonic acid metabolites, coagulation-fibrin system index) and adhesion molecules in the serum were detected by enzyme linked immunosorbent assay method; the Spearman method was used to analyze the correlation of those detection indicators; the partial least squares-discriminant analysis and multi-attribute comprehensive index method were used to comprehensively evaluate the total effect of GX herb pair samples with different proportions and preparation methods on vasoactive substances and adhesion molecules. The experimental scheme was approved by the Animal Experimental Ethics Committee of the First Affiliated Hospital of Henan University of Chinese Medicine. The results showed that GX 1∶1_WA had the strongest effect on the improvement of vasoactive substances and adhesion molecules in the serum of acute blood stasis in rats (the total effect value was 6.96). When extraction method was same, the overall effect of GX 1∶1 had better effect than that of other proportions; when the proportion of GX was same, the total effects of GX_WA and GX_A were better than GX_W. The combination of Danggui and Chuanxiong can significantly improve the expressions of vasoactive substances and adhesion molecules in the serum of blood stasis in rats. But the action strength of GX herb pairs was different when the proportions and preparations of GX herb pair were different. These findings provide a basis for clinical rational application of GX herb pair, and lay the foundation for in-depth research on GX herb pair for treatment of blood stasis related diseases.
10.Comparison of Risk Factors for the Progression of Coronary Lesions in Patients with Type 2 Diabetes and Non-diabetes Mellitus
Zhe-qi WEN ; Lei-le TANG ; Xing SHUI ; Jian-rui ZHENG ; Lin CHEN
Journal of Sun Yat-sen University(Medical Sciences) 2019;40(6):912-920
【Objective】Diabetes mellitus is a risk equivalent for coronary heart disease. This retrospective study was designed to investigate the risk factors of the progression of coronary lesions in patients with type 2 diabetes(T2DM)and Non- diabetes Mellitus(NDM).【Methods】 526 patients with T2DM and 425 patients with NDM at the Third Affiliated Hospital of Sun Yat-sen University between March 2001 and January 2017 who underwent coronary imaging studies(coronary angiography or coronary CTA)twice during the same period were enrolled. The effects of cardiovascular risk factors on the progression of coronary lesions were analyzed in parallel in these two types of patients.【Results】Risk factors of the progression of coronary lesions in T2DM patients included smoking(OR = 1.836,95% CI:1.030~3.371,P = 0.04),Lp(a) [OR = 1.001,95% CI:1.000~1.002,P = 0.004(baseline);OR = 1.001,95% CI:1.000~1.002,P = 0.009(re-examined)],HbA1c leve[l OR = 1.471,95% CI:1.030~2.100,P = 0.034(re-examined)],uncontrolled LDL-C(OR = 1.882,95% CI:1.091~3.245,P = 0.023),TC[OR = 2.029,95% CI:1.028~4.008,P = 0.041(re-examined)]and low HDL-C [OR = 0.017,95% CI:0.040~0.729,P = 0.017(re-examined)]. Comparative risk factors in NDM included BMI[OR =1.746,95%CI:2.462~2.712,P = 0.026(baseline);OR = 0.001,95%CI:0~0.394,P = 0.025(re-examined)],uncontrolled LDL-C(OR = 2.875,95%CI:1.669~4.952,P < 0.001)and low ApoA[OR = 0.282,95%CI:0.082~0.971,P = 0.045 (baseline);OR = 0.117,95%CI:0.038~0.835,P = 0.029(re-examined)]. Lowest level of progression was found in the group with HbA1c<6.5%[0(0~3.4)points/year vs 0.3(0~3.0)points/year vs 1.0(0~5.1)points/year,P = 0.049. 0(-0.4~2.7)points/year vs 0.6(0~4.0)points/year vs 0.9(0~4.2)points/year,P=0.029]in T2DM patients.【Conclusion】Except for achievement of LDL- C goals,there might be some differences in risk factors for progression of coronary lesions between T2DM and NDM patients. Smoking,Lp(a),TC,HDL- C and control levels of HbA1c are independent predictors in T2DM as well as BMI and ApoA in NDM. Lowering HbA1c to less than 6.5% may delay progression of lesion.

Result Analysis
Print
Save
E-mail